When:
November 10, 2018 @ 7:00 am – 3:00 pm
2018-11-10T07:00:00-05:00
2018-11-10T15:00:00-05:00

 

REGISTRATION: https://www.medlearninggroup.com/cme-programming/ons-mn-registration-confirmation/

Oncology Nurses Society – Quality Improvement Series 

Greater Minneapolis/St. Paul Oncology Nursing Society

Features: ONS QIS Website, Personalized Quality Improvement Posters and Online Enduring Smart Reach Programs  

(Multi-Support Initiative)
November 10th, 2018
W Minneapolis – The Foshay
821 Marquette Ave
Minneapolis, MN, 55402

Saturday, November 10th, 2018

Breakfast: 7:00AM – 8:00 AM

Meeting: 8:00 AM – 4:00 PM

Great Room 1/2

— 7 CNE Credits —

FACULTY/PRESENTATION TRACKS

Follicular Lymphoma:

“The Role of the Oncology Nurse in the Management of Follicular Lymphoma – Incorporating New Therapies and Applying Treatment Guidelines to the Clinical Practice Setting”

Amitkumar Mehta, MD

Assistant Professor,

Lymphoma Program, Hematology and Oncology,

University of Alabama at Birmingham, AL

Breast Cancer:

“The Unique Role of the Oncology Nurse in the Targeted Treatment Era of Breast Cancer”

Marilyn Johnston, MSN, FNP-BC, OCN
Director of Advanced Practice, Oncology

Laura and Isaac Perlmutter Cancer Center
New York, NY

“The Triple-Negative Paradox: Leveraging Breast Cancer Biology to Advance Quality-of-Life in the Metastatic Setting

William J. Gradishar MD FASCO FACP
Betsy Bramsen Professor of Breast Oncology & Professor of Medicine
Chief, Division of Hematology/Oncology
Deputy Director, Clinical Network
Director, Maggie Daley Center for Women’s Cancer Care
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Northwestern University Feinberg School of Medicine
Chicago, IL

Acute Myeloid Leukemia

 “The Unique Role of the Oncology Nurse in the Management of Patients with Acute Myeloid Leukemia”

Michael R. Grunwald, MD
Associate Director, Leukemia Division

Department of Hematologic Oncology and Blood Disorders
Levine Cancer Institute
Charlotte, NC

Melanoma

“Nursing Management of Patients with Malignant Melanoma”

Kathy Madden, RN, MSN, FNP-BC, AOCNP, APHN
NYU Melanoma Program I Clinical Cancer Center

New York, NY

Chronic Lymphocytic Leukemia

“Moving Beyond Chemotherapy in the Treatment of Patients with Chronic Lymphocytic Leukemia: Therapeutic and Management Considerations for Nursing”

Leslie A.  Andritsos, MD|
Associate Professor of Medicine

University of New Mexico
Hematology
Albuquerque, NM

Head and Neck Cancer

“Leveraging the Immune System to treat Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck”

Tanguy Y. Seiwert, MD
Associate Professor of Medicine
University of Chicago Medicine 
Chicago, IL

Registration Website: https://oncologynurse.wpengine.com

Includes: information about registration, clinical/provider tool kit, poster portal, additional resources

Target Audience

Oncology certified nurses and oncologists

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 7.0 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION
Purpose:
This program would be beneficial for nurses involved in the care of oncology patients.

Credits:
7 ANCC Contact Hour(s)

ACCREDITATION STATEMENT:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded a maximum of 7 contact hour(s) of continuing nursing education of RNs and APNs.

ONCC RECERTIFICATION POINTS

The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

This activity is provided by Med Learning Group.
This activity is co-provided by CCM.
This activity is implemented in partnership with Minneapolis/St. Paul ONS Chapter
Supported by educational grants from Abbvie, Bayer, Genentech, Lilly, Merck & Co. and Pharmacyclics